Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1992130 | 0.73 | MAPT (0.42) | ADORA2BMAPTACHEGDAXDH | |
| SCHEMBL30604637 | 0.73 | MAPT (0.48) | ADORA2BMAPTACHEGDAXDH | |
| SCHEMBL31695004 | 0.72 | GAA (0.38) | ADORA2BMAPTXDH | |
| SCHEMBL3085104 | 0.69 | LMNA (0.52) | ADORA2BMAPTACHEGDAXDH | |
| SCHEMBL8750703 | 0.69 | ADORA2B (0.49) | ADORA2BMAPTXDHALDH1A1HSD17B10 | |
| SCHEMBL31695008 | 0.69 | PNP (0.49) | GDAXDHALDH1A1 | |
| SCHEMBL10868836 | 0.68 | ADORA2B (0.34) | ADORA2BMAPTXDH | |
| SCHEMBL7801075 | 0.68 | MAPT (0.43) | ADORA2BMAPTACHEGDAXDH | |
| SCHEMBL9430257 | 0.68 | PDE3B (0.39) | ADORA2BMAPTACHEGDAXDH | |
| SCHEMBL2143500 | 0.67 | MAPT (0.46) | ADORA2BMAPTACHEGDAXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250314666-A1 | DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS BASED ON AMINE CONTAINING METABOTYPES | STEMINA BIOMARKER DISCOVERY INC (US) | 2025-10-09 | — | — | US | disclosed |